RecruitingNCT06913998

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Sponsor

National Taiwan University Hospital

Enrollment

65 participants

Start Date

Dec 27, 2023

Study Type

OBSERVATIONAL

Conditions

Inflammatory Bowel Diseases Neutropenia Nudt15 Deficiency

Summary

The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.

Eligibility

Min Age: 1 YearMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with inflammatory bowel diseases, neutropenia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.